COVID-19 With Preexisting Hypercoagulability Digestive Disease
oleh: Mingshan Jiang, Mingshan Jiang, Mingshan Jiang, Jingxi Mu, Jingxi Mu, Jingxi Mu, Silan Shen, Silan Shen, Silan Shen, Hu Zhang, Hu Zhang, Hu Zhang
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2021-01-01 |
Deskripsi
The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease.